Development of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 3CLpro.
ACS Cent Sci
; 9(2): 217-227, 2023 Feb 22.
Article
in En
| MEDLINE
| ID: mdl-36844503
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
ACS Cent Sci
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
United States